Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era.

Bookmark this %label%

The present analysis aims to evaluate the consequences of a 2-month interruption of mammographic screening on breast cancer (BC) stage at diagnosis and upfront treatments in a region of Northern […]

» Read more

Supportive care in patients with cancer during the COVID-19 pandemic.

Bookmark this %label%

Cancer care has been profoundly impacted by the global pandemic of severe acute respiratory syndrome coronavirus 2 disease (coronavirus disease 2019, COVID-19), resulting in unprecedented challenges. Supportive care is an […]

» Read more

Knowledge, attitudes and practices related to the COVID-19 outbreak among Romanian adults with cancer: a cross-sectional national survey.

Bookmark this %label%

The coronavirus disease 2019 (COVID-19) pandemic outbreak forced cancer care providers to face different challenges in terms of prevention and treatment management due to specific precautions implemented for oncological patients. […]

» Read more

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future.

Bookmark this %label%

This study evaluated the consequences in Europe of the COVID-19 outbreak on pathology laboratories orientated toward the diagnosis of thoracic diseases.A survey was sent to 71 pathology laboratories from 21 […]

» Read more

Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome.

Bookmark this %label%

Cancer patients are at increased risk of death from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cancer and its treatment affect many haematological and biochemical parameters, therefore we analysed these […]

» Read more

Impact of COVID-19 on cancer service delivery: results from an international survey of oncology clinicians.

Bookmark this %label%

To report clinician-perceived changes to cancer service delivery in response to COVID-19.Multidisciplinary Australasian cancer clinician survey in collaboration with the European Society of Medical Oncology.Between May and June 2020 clinicians […]

» Read more

COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study.

Bookmark this %label%

In the midst of the COVID-19 pandemic, patients with cancer are regarded as a highly vulnerable population. Overall, those requiring hospital admission for treatment administration are potentially exposed to a […]

» Read more

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy.

Bookmark this %label%

Life-threatening diseases have a negative impact on emotional well-being and psychosocial functioning. This study aimed to assess the relationship between the level of anxiety caused by a neoplasm and the […]

» Read more

Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis.

Bookmark this %label%

Cancer seems to have an independent adverse prognostic effect on COVID-19-related mortality, but uncertainty exists regarding its effect across different patient subgroups. We report a population-based analysis of patients hospitalised […]

» Read more

Optimising triage procedures for patients with cancer needing active anticancer treatment in the COVID-19 era.

Bookmark this %label%

Immunosuppression induced by anticancer therapy in a COVID-19-positive asymptomatic patient with cancer may have a devastating effect and, eventually, be lethal. To identify asymptomatic cases among patients receiving active cancer […]

» Read more

SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.

Bookmark this %label%

During the COVID-19 outbreak, healthcare professionals (HCP) are at the frontline of clinical management and at increased risk for infection. The SARS-CoV-2 seroprevalence of oncological HCP and their patients has […]

» Read more

ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies.

Bookmark this %label%

The rapid spread of severe acute respiratory syndrome coronavirus 2 infection and its related disease (COVID-19) has required an immediate and coordinate healthcare response to face the worldwide emergency and […]

» Read more

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma.

Bookmark this %label%

The coronavirus pandemic has provoked discussions among healthcare providers how to manage cancer patients when faced with the threat of severe acute respiratory syndrome related coronavirus 2 (SARS-CoV-2) infection. Immune […]

» Read more

ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancer.

Bookmark this %label%

The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, […]

» Read more

Infection rate and clinical management of cancer patients during the COVID-19 pandemic: experience from a tertiary care hospital in northern Italy.

Bookmark this %label%

Optimal management of patients with cancer during COVID-19 pandemic is still pending.Our patients were advised to maintain their scheduled appointments, and planned cancer treatment was continued without unnecessary delays in […]

» Read more

ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancer.

Bookmark this %label%

COVID-19 pandemic challenges health system capacities in many countries. National healthcare services have to manage unexpected shortage of healthcare resources that have to be reallocated according to the principles of […]

» Read more

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.

Bookmark this %label%

The global preparedness and response to the rapid escalation to severe acute respiratory syndrome coronavirus (SARS-CoV)-2-related disease (COVID-19) to a pandemic proportion has demanded the formulation of a reliable, useful […]

» Read more

ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer.

Bookmark this %label%

The COVID-19 pandemic is challenging the capacities of health systems in many countries. National healthcare services have to manage unexpected shortages of healthcare resources that have to be re-allocated according […]

» Read more

How we treat patients with brain tumour during the COVID-19 pandemic.

Bookmark this %label%

The COVID-19 pandemic has created major insecurities regarding whether we can and should maintain the current standards of diagnosis and treatment and access to care for patients with cancer. This […]

» Read more

How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere.

Bookmark this %label%

New cases of the novel coronavirus, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continue to rise worldwide. A few reports have showed that mortality due to SARS-CoV-2 […]

» Read more
1 2